1. High-Dose Carmustine, Etoposide, and Cyclophosphamide Followed by Allogeneic Hematopoietic Cell Transplantation for Non-Hodgkin Lymphoma 
Lisa Y. Law, Sandra J. Horning, Ruby M. Wong, Laura J. Johnston, Ginna G. Laport, Robert Lowsky, Judith A. Shizuru, Karl G. Blume, Robert S. Negrin, Keith E. Stockerl-Goldstein 
Biology of Blood and Marrow Transplantation 
Volume 12, Issue 7, Pages (July 2006)
DOI: /j.bbmt
Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
OS (solid line) and EFS (dashed line) probabilities for 31 patients treated with CBV followed by allogeneic HCT.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Probabilities of NRM (solid line) and relapse (dashed line) for 31 patients treated with CBV followed by allogeneic HCT.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2006 American Society for Blood and Marrow Transplantation Terms and Conditions